US Stock MarketDetailed Quotes

HLVX HilleVax

Watchlist
  • 1.810
  • +0.010+0.56%
Close Feb 26 16:00 ET
90.15MMarket Cap-0.59P/E (TTM)

About HilleVax Company

HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.

Company Profile

SymbolHLVX
Company NameHilleVax
Listing DateApr 29, 2022
Issue Price17.00
Founded2020
CEODr. Robert M. Hershberg, M.D.,PhD
MarketNASDAQ
Employees90
Fiscal Year Ends12-31
Address321 Harrison Avenue,Suite 500
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02118
Phone1-617-213-5054
Websitehttp://www.hillevax.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Robert M. Hershberg, M.D.,PhD
  • Chairman of the Board, President and Chief Executive Officer
  • 9.70M
  • Paul S. Bavier
  • General Counsel and Chief Administrative Officer
  • --
  • Shane Maltbie
  • Vice of President, Finance, Chief Financial Officer and Principal Accounting Officer
  • --
  • Aditya Kohli, PhD
  • Director
  • 4.08M
  • Dr. Gary Dubin, M.D.
  • Director
  • --
  • Dr. Jaime Sepulveda, D.Sc.,M.D.,M.P.H.
  • Independent Director
  • 353.11K
  • Patrick J. Heron
  • Independent Director
  • 367.11K
  • Dr. Nanette Cocero, M.B.A.,PhD
  • Independent Director
  • 555.03K
  • Jeryl L. Hilleman
  • Independent Director
  • 375.11K
  • Dr. Shelley Chu, PhD
  • Independent Director
  • 355.11K
  • Dr. Julie L. Gerberding, M.D.,M.P.H.
  • Independent Director
  • 365.93K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
WANDA BEARING
920002
+30.00%
HENDERA
831152
+29.97%
LINGOOD
833284
+29.95%
4
WUHAN LAND
830779
+25.43%
5
TECHVISION
832876
+21.28%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.